Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT01186575
Collaborator
University of Illinois at Chicago (Other), Kenya Medical Research Institute (Other)
1,200
1
2
10
120.1

Study Details

Study Description

Brief Summary

Male circumcision (MC) reduces, by more than half, the risk of HIV-1 acquisition. WHO and UNAIDS recommend that "male circumcision should be recognized as an efficacious intervention for HIV prevention especially in countries and regions with heterosexual HIV epidemics and low male circumcision prevalence." As a result, programs have been introduced and scaled up for voluntary medical male circumcision. Kenya leads with the largest expansion of services.

Early resumption of sexual intercourse after MC may have deleterious effects, including higher rates of post-operative surgical complications, and higher HIV acquisition among females in couples that resume sexual activity before certified wound healing. In the context of rapid scale-up of MC, adherence to post-operative clinic appointments allows clinicians to assess wound healing and to deliver risk reduction counseling. Abstinence from sexual intercourse before complete wound healing would reduce the rate of post-operative adverse events and minimize the risk of HIV transmission from HIV-infected men to their uninfected female partners.

To the investigators knowledge, the effect of reminders delivered via text messaging to promote adherence to clinic visits and abstinence after MC has not been investigated. The investigators propose a randomized controlled trial in which men who will have undergone voluntary medical male circumcision at selected sites in Kisumu will be randomized to receive either the intervention (context-sensitive text messages after circumcision) or the control condition (usual care). This study seeks to determine (a) the effect of regular text messages sent to men after circumcision on attendance of the scheduled 7-day post-operative clinic visit versus usual care; (b) the proportion of men who resume sexual activity before 42 days post-procedure after receiving regular text messages versus usual care within the 42 days post-circumcision; and (c) to identify potential predictors of failure to attend the scheduled 7-day post-operative visit and early resumption of sexual intercourse.

Condition or Disease Intervention/Treatment Phase
  • Other: Text Message
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
1200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Text Messaging to Improve Adherence to Post-Operative Clinic Appointments and Reduce Early Resumption of Sexual Intercourse After Adult Male Circumcision: A Randomized Controlled Trial
Study Start Date :
Aug 1, 2010
Actual Primary Completion Date :
Mar 1, 2011
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: Text Message

Context-sensitive text messages are sent to men after undergoing circumcision

Other: Text Message
Context-sensitive text messages are sent to men after undergoing circumcision
Other Names:
  • SMS, short message service, text messaging
  • No Intervention: Usual Care

    Usual care after adult male circumcision (no text messages)

    Outcome Measures

    Primary Outcome Measures

    1. Proportion of men failing to return for a post-operative clinic visit at 7 days. [7 days]

      This proportion will be determined by examining each participant's clinic records after their 7th post-operative day. Adherence to this clinic visit will be analyzed as a dichotomous variable.

    2. Proportion of men who report resumption of sexual activity before 42 days post-circumcision. [42 days]

      This proportion will be determined by self-report using a brief questionnaire delivered via phone call. The analysis will be as a dichotomous variable, with participants considered as having either 'resumed' or 'not resumed.'

    Secondary Outcome Measures

    1. Time to resumption of sex by study arm [42 days]

    2. Correlates of failure to attend the scheduled 7-day post-operative visit [42 days]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Male

    • 18 years or older

    • Have undergone circumcision on the day they are screened for the study

    • Currently own a mobile phone with text-messaging capability, and

    • Have the mobile phone in their possession at the time of enrollment

    • Able and willing to respond to a questionnaire administered via a phone call

    Exclusion Criteria:
    • Prior participation in a study on male circumcision

    • Currently participating in other ongoing research studies

    • Any medical condition or situation exists such that study participation would not be in the man's best interest, as determined by the investigator

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Nyanza Reproductive Health Society Kisumu Nyanza Kenya

    Sponsors and Collaborators

    • University of Washington
    • University of Illinois at Chicago
    • Kenya Medical Research Institute

    Investigators

    • Principal Investigator: Thomas A Odeny, MBChB, MPH, University of Washington
    • Study Chair: R S McClelland, MD, MPH, University of Washington
    • Study Chair: Elizabeth A Bukusi, MBChB, MMed, MPH, PhD, Kenya Medical Research Institute
    • Study Chair: Jane Simoni, PhD, University of Washington
    • Study Chair: King K Holmes, MD, PhD, University of Washington
    • Study Chair: Robert C Bailey, PhD, MPH, University of Illinois at Chicago

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Thomas Odeny, Investigator, University of Washington
    ClinicalTrials.gov Identifier:
    NCT01186575
    Other Study ID Numbers:
    • 38465-E/G
    First Posted:
    Aug 23, 2010
    Last Update Posted:
    Jan 16, 2015
    Last Verified:
    Jan 1, 2015

    Study Results

    No Results Posted as of Jan 16, 2015